Lamivudine + Zidovudine + Abacavir

Abacavir/lamivudine/zidovudine, sold under the brand name Trizivir, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS.[2][3][4] It contains three reverse transcriptase inhibitors patented by GlaxoSmithKline and marketed by a joint venture with Pfizer, ViiV Healthcare:[5] abacavir sulfate (ABC) lamivudine (3TC) zidovudine (AZT or ZDV) It is indicated in the treatment of AIDS/HIV-1.[2&... [wikipedia]